Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Oral Oncol. 2012 Nov 17;49(4):360–366. doi: 10.1016/j.oraloncology.2012.10.004

Table 1.

Demographic and clinical characteristics of the original and final samples.

Variables Original sample (N = 721)
mean ± SD or N (%)
Final sample (N = 684)
mean ± SD or N (%)
Demographic characteristics
Age (years) 55.78 ± 8.84 55.70 ± 8.84
Gender
Male 597 (83) 564 (83)
Female 124 (17) 120 (17)
Racea
White 589 (82) 558 (82)
Non-White 130 (18) 124 (18)
Educationa
≤12 years 400 (63) 379 (63)
>12 years 231 (37) 222 (37)
Marital statusa,b
Married 380 (56) 361 (56)
Unmarried 296 (44) 283 (44)
History of tobacco usea
No 113 (18) 110 (18)
Yes 525 (82) 500 (82)
Clinical characteristics
Radiation dose (Gy) 69.88 ± 8.43 71.24 ± 1.43
Treatment
SFRT + cisplatin 361 (50) 349 (51)
AFRT + cisplatin 360 (50) 335 (49)
Primary cancer site
Non-larynx 533 (74) 508 (74)
Larynx 188 (26) 176 (26)
Stage
III 158 (22) 149 (22)
IV 563 (78) 535 (78)
Tube feeding
No 553 (77) 531 (77)
Yes 168 (23) 153 (23)

SD = standard deviation, SFRT = standard fractionation radiotherapy, AFRT = Accelerated fractionation radiotherapy. Statistically significant differences are high-lighted in bold text.

a

Having missing cases: Race (original sample: 2; final sample: 2); Education (original sample: 90; final sample: 83); Marital status (original sample: 45; final sample: 40); History of tobacco use (original sample: 83; final sample: 74).

b

Married includes patients married or living as married; Unmarried includes patients single, separated, divorced, or widowed.